论文部分内容阅读
1975年日人森满保等报告用泛影葡胺(diatrizoate meglumine)治疗暴聋获得良好效果,并据此提出血管纹功能紊乱引起暴聋的新看法。原始病例是一57岁男性暴聋患者,曾接受激素、维生素、血管扩张剂及星状神经节封闭等治疗,听力没有增进。发病后40天,准备作椎动脉造影以除外血管畸形,先用泛影葡胺1毫升静脉注射作过敏试验,经30分钟后,患者感到耳鸣显著减
In 1975, Morinaga Mori et al reported good results in the treatment of deafness with diatrizoate meglumine, and accordingly proposed a new belief that deafness caused by vascular pattern dysfunction. The original case was a 57-year-old male with deafness who had received treatment for hormones, vitamins, vasodilators and stellate ganglion without improvement of hearing. Forty days after the onset of the disease, preparation for vertebral artery angiography was performed to exclude vascular malformations. First, an intravenous injection of diatrizoate meglumine for hypersensitivity test was used. After 30 minutes, the patient felt tinnitus significantly